Skip to main content

Advertisement

Table 2 Relationship between the level of MDA-LDL and various parameters in univariate analyses

From: Impact of dyslipidemic components of metabolic syndrome, adiponectin levels, and anti-diabetes medications on malondialdehyde-modified low-density lipoprotein levels in statin-treated diabetes patients with coronary artery disease

  r p
Age 0.010 0.887
Body mass index −0.023 0.739
Waist circumference 0.025 0.724
Systolic blood pressure 0.075 0.281
Creatinine 0.036 0.600
Hemoglobin A1c 0.068 0.330
LDL cholesterol 0.458 <0.0001
Triglycerides* 0.435 <0.0001
HDL cholesterol −0.164 0.017
Adiponectin* −0.227 0.001
  1. Abbreviations: HDL high-density lipoprotein, LDL low-density lipoprotein, MDA-LDL malondialdehyde-modified LDL.
  2. Statistical analyses were performed using simple regression.
  3. *Log-transformed values were subjected to statistical analyses.